Skip to main content
Back
UHS logo

Universal Health Services, Inc.

Data quality: 100%
UHS
NYSE Healthcare Medical - Care Facilities
$185.92
▼ $2.17 (-1.15%)
Mkt Cap: 11.82B
Day Range
$181.81 $188.93
52-Week Range
$152.33 $246.33
Volume
526,900
50D / 200D Avg
$207.33 / $200.41
Prev Close
$188.09

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (627 peers)

Metric Stock Sector Median
P/E 7.9 0.3
P/B 1.6 2.9
ROE % 21.4 3.7
Net Margin % 8.6 3.8
Rev Growth 5Y % 8.3 10.0
D/E 0.8 0.2

Analyst Price Target

Hold
$245.67 +32.1%
Low: $219.00 High: $274.00
Forward P/E
8.0
Forward EPS
$23.44
EPS Growth (est.)
+0.0%
Est. Revenue
18 B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2029 $28.77
$27.74 – $29.24
 21 B 4
FY2028 $28.25
$26.68 – $31.03
 20 B 6
FY2027 $25.57
$23.79 – $28.09
 19 B 11

Key Takeaways

Revenue grew 8.26% annually over 5 years — modest growth
Earnings grew 30.36% over the past year
ROE of 21.36% indicates high profitability
Generating 849.25M in free cash flow
P/E of 7.94 — trading at a low valuation
PEG of 0.26 suggests growth is underpriced

Growth

Revenue Growth (5Y)
8.26%
Revenue (1Y)9.71%
Earnings (1Y)30.36%
FCF Growth (3Y)27.22%

Quality

Return on Equity
21.36%
ROIC11.70%
Net Margin8.57%
Op. Margin11.48%

Safety

Debt / Equity
0.76
Current Ratio1.05
Interest Coverage12.68

Valuation

P/E Ratio
7.94
P/B Ratio1.62
EV/EBITDA8.62
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 9.71% Revenue Growth (3Y) 10.27%
Earnings Growth (1Y) 30.36% Earnings Growth (3Y) 44.02%
Revenue Growth (5Y) 8.26% Earnings Growth (5Y) 10.69%
Profitability
Revenue (TTM) 17.36B Net Income (TTM) 1.49B
ROE 21.36% ROA 9.33%
Gross Margin 90.45% Operating Margin 11.48%
Net Margin 8.57% Free Cash Flow (TTM) 849.25M
ROIC 11.70% FCF Growth (3Y) 27.22%
Safety
Debt / Equity 0.76 Current Ratio 1.05
Interest Coverage 12.68 Dividend Yield 0.00%
Valuation
P/E Ratio 7.94 P/B Ratio 1.62
P/S Ratio 0.68 PEG Ratio 0.26
EV/EBITDA 8.62 Dividend Yield 0.00%
Market Cap 11.82B Enterprise Value 17.19B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 17.36B 15.83B 14.28B 13.40B 12.64B
Net Income 1.49B 1.14B 717.80M 675.61M 991.59M
EPS (Diluted) 23.10 16.82 10.23 9.14 11.82
Gross Profit 15.71B 14.24B 12.75B 11.93B 11.21B
Operating Income 1.99B 1.68B 1.18B 1.00B 1.36B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15.96B 14.47B 13.97B 13.49B 13.09B
Total Liabilities 8.55B 7.71B 7.77B 7.52B 6.90B
Shareholders' Equity 7.28B 6.67B 6.15B 5.92B 6.09B
Total Debt 5.51B 4.96B 5.37B 5.27B 4.56B
Cash & Equivalents 137.80M 125.98M 119.44M 102.82M 115.30M
Current Assets 3.41B 2.82B 2.81B 2.54B 2.26B
Current Liabilities 3.24B 2.21B 2.01B 1.91B 1.98B

Strategy Scores

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#377 of 618
28
Custom Contrarian Investing (David Dreman)
#220 of 670
42
Custom Balanced Risk
#147 of 151
23
Custom Lower Risk
#131 of 140
27

Recent Activity

Entered Contrarian Investing (David Dreman)
Mar 25, 2026
Entered Balanced Risk
Mar 25, 2026
Entered Lower Risk
Mar 25, 2026
Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026